文献速递脊柱关节炎

银屑病关节炎的死亡率:风险、死因与死亡预测因素

Mortality in psoriatic arthritis: Risk, causes of death, predictors for death.
PubMed 文献 · Semin Arthritis Rheum · 2020-05-23

基于多伦多银屑病关节炎前瞻队列1490例患者、15062.8患者年的研究显示,总体标准化死亡比(SMR)为0.92(95%CI 0.81-1.05),男性SMR为0.81(95%CI 0.66-0.97),20-39岁年龄组SMR为3.36(95%CI 1.61-6.18)。主要死因包括恶性肿瘤、急性心肌梗死和肺炎,疾病活动指标升高、合并心脏病或癌症及低教育水平与死亡风险增加相关。

要点

  • 年轻银屑病关节炎患者(20-39岁)死亡风险显著升高,SMR为3.36。
  • 男性患者SMR低于一般人群(0.81,95%CI 0.66-0.97),女性无显著差异。
  • 肺炎死亡风险升高(SMR=2.46,95%CI 1.27-4.31),需重视感染防控。

核心结论

  • 年轻银屑病关节炎患者死亡风险增加,更好地控制合并症可能降低该风险。

研究设计与样本

  • 多伦多银屑病关节炎诊所前瞻性队列研究,1490例患者按标准方案每6-12个月随访,共15062.8患者年。
  • 计算总体、年龄别和性别别标准化死亡比(SMR),以安大略省人群为参照,按ICD9/ICD10记录死因并计算死因别SMR,采用Cox回归分析死亡预测因素。

主要发现

  • 共记录225例(15%)确认死亡(女性111例,男性114例),总体SMR为0.92(95%CI 0.81-1.05)。
  • 女性SMR为1.08(95%CI 0.89-1.30),男性SMR为0.81(95%CI 0.66-0.97)。
  • 20-39岁、40-59岁、60-79岁及80岁以上年龄别SMR分别为3.36(95%CI 1.61-6.18)、0.97(95%CI 0.68-1.34)、0.88(95%CI 0.73-1.06)和0.86(95%CI 0.66-1.11)。
  • 主要死因包括恶性肿瘤(n=61;SMR=0.97,95%CI 0.72-1.28)、急性心肌梗死(n=32;SMR=1.11,95%CI 0.74-1.58)和肺炎(n=14;SMR=2.46,95%CI 1.27-4.31)。
  • 与死亡风险增加相关的因素包括急性期反应物升高、合并心脏病和癌症等共病以及较低教育水平。

临床怎么用

  • 对年轻银屑病关节炎患者应加强死亡风险评估与随访管理。
  • 积极控制合并症(尤其心脏病、癌症)可能有助于降低死亡风险。
  • 关注肺炎相关死亡风险升高,临床中需重视感染预防与监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVES: Mortality studies in psoriatic arthritis (PsA) have provided inconsistent results. This study aimed to: 1) Estimate trends in mortality rates among PsA patients over calendar time; 2) Evaluate cause-specific mortality rates in patients with PsA compared to the general population; 3) Identify predictors for mortality in PsA. METHODS: The study was carried out at the University of Toronto Psoriatic Arthritis Clinic where patients are followed prospectively according to a standard protocol at 6- to 12- month intervals. Standardized mortality ratios (SMRs) were calculated overall, by age, and by sex with reference to the Ontario population. Causes of death were recorded by ICD9 and ICD10 codes and cause-specific SMRs were computed. Cox regression models were used to identify predictors for mortality among PsA patients. RESULTS: Among 1490 patients followed over 15062.8 patient-years, 225 (15%) confirmed deaths were recorded (111 females, 114 males). The overall SMR was 0.92 (95% CI: 0.81-1.05), the sex-specific SMRs were 1.08 (95% CI: 0.89-1.30) for females and 0.81 (95% CI: 0.66-0.97) for males. The age-specific SMRs were 3.36 (95% CI: 1.61-6.18), 0.97 (95% CI: 0.68-1.34), 0.88 (95% CI: 0.73-1.06) and 0.86 (95% CI: 0.66-1.11) for 20-39, 40-59, 60-79 and above 80 years of age, respectively. Major causes of death included malignant neoplasms (n=61; SMR=0.97, 95% CI: 0.72-1.28), acute myocardial infarction (n=32; SMR=1.11, 95% CI: 0.74-1.58), and pneumonia (n=14; SMR=2.46, 95% CI: 1.27-4.31). Factors found to be associated with increased mortality include elevated acute phase reactants, presence of comorbidities such as heart disease and cancer, and lower education level. CONCLUSION: Young patients with PsA are at increased mortality risk. Better control of comorbidities may reduce this risk.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Elalouf O, Muntyanu A, Polachek A, et al. Mortality in psoriatic arthritis: Risk, causes of death, predictors for death. Semin Arthritis Rheum. 2020. PMID: 32454305. doi:10.1016/j.semarthrit.2020.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。